Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    18216355 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection
Conditions: Kidney Transplantation;   Kidney Failure, Chronic
Interventions: Procedure: Kidney Transplant;   Procedure: Bone marrow transplant;   Biological: MEDI-507;   Drug: Cyclophosphamide;   Biological: Rituximab;   Drug: Tacrolimus;   Drug: Corticosteroids;   Radiation: Radiation to the thymus gland
2 Completed Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant
Conditions: Kidney Failure;   Bone Marrow Transplantation;   Kidney Transplantation;   Kidney Failure, Chronic
Interventions: Drug: MEDI-507;   Procedure: Combined kidney and bone marrow transplant;   Drug: Cyclosporine A;   Drug: Rituximab;   Drug: Corticosteroids
3 Recruiting Renal Allograft Tolerance Through Mixed Chimerism
Condition: End Stage Renal Disease
Interventions: Drug: MEDI-507;   Drug: Rituximab;   Radiation: Total Body Irradiation;   Radiation: Thymic Irradiation

Indicates status has not been verified in more than two years